The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologic Therapeutics Drugs Market Research Report 2024
Synopsis
The global Biologic Therapeutics Drugs market was valued at US$ 322420 million in 2023 and is anticipated to reach US$ 487360 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics Drugs.
Report Scope
The Biologic Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologic Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Segment by Type
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biologic Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Biologic Therapeutics Drugs market was valued at US$ 322420 million in 2023 and is anticipated to reach US$ 487360 million by 2030, witnessing a CAGR of 6.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics Drugs.
Report Scope
The Biologic Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologic Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologic Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
AstraZeneca
Novartis
Merck
Smith Medical
GlaxoSmithKline
Concord Biotech
Aurobindo Pharma
H. Lundbeck
Retractable Technologies
Segment by Type
Avian Cell Culture
Yeast
Bacteria
Insects Cell Culture
Transgenics
Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biologic Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Biologic Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Biologic Therapeutics Drugs
1.2 Biologic Therapeutics Drugs Segment by Type
1.2.1 Global Biologic Therapeutics Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Avian Cell Culture
1.2.3 Yeast
1.2.4 Bacteria
1.2.5 Insects Cell Culture
1.2.6 Transgenics
1.3 Biologic Therapeutics Drugs Segment by Application
1.3.1 Global Biologic Therapeutics Drugs Market Value by Application: (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Biologic Therapeutics Drugs Revenue 2019-2030
1.4.2 Global Biologic Therapeutics Drugs Sales 2019-2030
1.4.3 Global Biologic Therapeutics Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Biologic Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Biologic Therapeutics Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Biologic Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Biologic Therapeutics Drugs, Product Type & Application
2.7 Biologic Therapeutics Drugs Market Competitive Situation and Trends
2.7.1 Biologic Therapeutics Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue
2.7.3 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biologic Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Biologic Therapeutics Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Biologic Therapeutics Drugs Global Biologic Therapeutics Drugs Sales by Region: 2019-2030
3.2.1 Global Biologic Therapeutics Drugs Sales by Region: 2019-2024
3.2.2 Global Biologic Therapeutics Drugs Sales by Region: 2025-2030
3.3 Global Biologic Therapeutics Drugs Global Biologic Therapeutics Drugs Revenue by Region: 2019-2030
3.3.1 Global Biologic Therapeutics Drugs Revenue by Region: 2019-2024
3.3.2 Global Biologic Therapeutics Drugs Revenue by Region: 2025-2030
3.4 North America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Biologic Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Biologic Therapeutics Drugs Sales by Country (2019-2030)
3.4.3 North America Biologic Therapeutics Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Biologic Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Biologic Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Biologic Therapeutics Drugs Sales by Country (2019-2030)
3.5.3 Europe Biologic Therapeutics Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Biologic Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Biologic Therapeutics Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Biologic Therapeutics Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Biologic Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Biologic Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Biologic Therapeutics Drugs Sales by Country (2019-2030)
3.7.3 Latin America Biologic Therapeutics Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Biologic Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Biologic Therapeutics Drugs Sales by Type (2019-2030)
4.1.1 Global Biologic Therapeutics Drugs Sales by Type (2019-2024)
4.1.2 Global Biologic Therapeutics Drugs Sales by Type (2025-2030)
4.1.3 Global Biologic Therapeutics Drugs Sales Market Share by Type (2019-2030)
4.2 Global Biologic Therapeutics Drugs Revenue by Type (2019-2030)
4.2.1 Global Biologic Therapeutics Drugs Revenue by Type (2019-2024)
4.2.2 Global Biologic Therapeutics Drugs Revenue by Type (2025-2030)
4.2.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Biologic Therapeutics Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Biologic Therapeutics Drugs Sales by Application (2019-2030)
5.1.1 Global Biologic Therapeutics Drugs Sales by Application (2019-2024)
5.1.2 Global Biologic Therapeutics Drugs Sales by Application (2025-2030)
5.1.3 Global Biologic Therapeutics Drugs Sales Market Share by Application (2019-2030)
5.2 Global Biologic Therapeutics Drugs Revenue by Application (2019-2030)
5.2.1 Global Biologic Therapeutics Drugs Revenue by Application (2019-2024)
5.2.2 Global Biologic Therapeutics Drugs Revenue by Application (2025-2030)
5.2.3 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Biologic Therapeutics Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Biologic Therapeutics Drugs Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Biologic Therapeutics Drugs Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Smith Medical
6.5.1 Smith Medical Corporation Information
6.5.2 Smith Medical Description and Business Overview
6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
6.5.5 Smith Medical Recent Developments/Updates
6.6 GlaxoSmithKline
6.6.1 GlaxoSmithKline Corporation Information
6.6.2 GlaxoSmithKline Description and Business Overview
6.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
6.6.5 GlaxoSmithKline Recent Developments/Updates
6.7 Concord Biotech
6.6.1 Concord Biotech Corporation Information
6.6.2 Concord Biotech Description and Business Overview
6.6.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
6.7.5 Concord Biotech Recent Developments/Updates
6.8 Aurobindo Pharma
6.8.1 Aurobindo Pharma Corporation Information
6.8.2 Aurobindo Pharma Description and Business Overview
6.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
6.8.5 Aurobindo Pharma Recent Developments/Updates
6.9 H. Lundbeck
6.9.1 H. Lundbeck Corporation Information
6.9.2 H. Lundbeck Description and Business Overview
6.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
6.9.5 H. Lundbeck Recent Developments/Updates
6.10 Retractable Technologies
6.10.1 Retractable Technologies Corporation Information
6.10.2 Retractable Technologies Description and Business Overview
6.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
6.10.5 Retractable Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biologic Therapeutics Drugs Industry Chain Analysis
7.2 Biologic Therapeutics Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biologic Therapeutics Drugs Production Mode & Process
7.4 Biologic Therapeutics Drugs Sales and Marketing
7.4.1 Biologic Therapeutics Drugs Sales Channels
7.4.2 Biologic Therapeutics Drugs Distributors
7.5 Biologic Therapeutics Drugs Customers
8 Biologic Therapeutics Drugs Market Dynamics
8.1 Biologic Therapeutics Drugs Industry Trends
8.2 Biologic Therapeutics Drugs Market Drivers
8.3 Biologic Therapeutics Drugs Market Challenges
8.4 Biologic Therapeutics Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
